Delivra Health Brands Inc. DHBUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.24M | 8.13M | 9.38M | 9.60M | 9.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.24M | 8.13M | 9.38M | 9.60M | 9.59M |
| Cost of Revenue | 3.83M | 4.43M | 4.82M | 4.82M | 4.73M |
| Gross Profit | 2.41M | 3.70M | 4.56M | 4.78M | 4.86M |
| SG&A Expenses | 3.88M | 4.17M | 4.28M | 4.41M | 4.56M |
| Depreciation & Amortization | 19.60K | 229.20K | 456.40K | 689.30K | 908.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.73M | 8.83M | 9.56M | 9.92M | 10.19M |
| Operating Income | -1.49M | -696.10K | -179.70K | -319.10K | -600.80K |
| Income Before Tax | -1.63M | -735.20K | -279.80K | -565.10K | -849.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.63 | -0.74 | -0.28 | -0.57 | -0.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.63M | -735.20K | -279.80K | -565.10K | -849.50K |
| EBIT | -1.49M | -696.10K | -179.70K | -319.10K | -600.80K |
| EBITDA | -1.47M | -466.90K | 276.70K | 370.20K | 307.90K |
| EPS Basic | -0.05 | -0.02 | -0.01 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.03 | -0.02 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.05 | -0.02 | -0.01 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.03 | -0.02 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 125.05M | 125.05M | 125.05M | 125.05M | 123.85M |
| Average Diluted Shares Outstanding | 125.05M | 125.05M | 125.05M | 125.05M | 123.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |